Eisai to Present Abstracts on Oncology Products and Pipeline at ESMO Virtual Congress 2021
TOKYO, Sep 14, 2021 ̵ […]
ป้ายกำกับ: patients
Adlai Nortye Announces First Patient Dosed in Phase Ia Clinical Trial of AN2025 and AN0025 in Combination with atezolizumab for Advanced Solid Tumors
NEW JERSEY, the U.S. and […]
Eisai’s Anti-Epileptic Drug Fycompa Approved In China As Monotherapy For Partial-Onset Seizures And Pediatric Indication For Partial-Onset Seizures
TOKYO, Aug 2, 2021 – […]
Eisai: FDA Approves LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Combination for Patients With Certain Types of Advanced Endometrial Carcinoma
TOKYO and KENILWORTH, N.J […]
Eisai Launchs Bile Acid Transporter Inhibitor Goofice in Thailand
TOKYO, Jul 19, 2021 ̵ […]
Biogen and Eisai launch initiatives to help patients with Alzheimer’s disease access ADUHELM
Cambridge, MA, Jun 8, 202 […]
FDA grants accelerated approval for ADUHELM as the first and only Alzheimer’s disease treatment to address a defining pathology of the disease
TOKYO, Jun 8, 2021 – […]
Eisai to Present Data on Oncology Pipeline and Products at ASCO Annual Meeting
TOKYO, May 20, 2021 ̵ […]
Anticancer Agent “Remitoro Intravenous Drip Infusion 300 microgram” (Denileukin Diftitox (Genetical Recombination)) Launched in Japan
Tokyo, May 19, 2021 ̵ […]